The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Independent validation of a genomic classifier in an at-risk population of men conservatively managed after radical prostatectomy.
Eric A. Klein
Research Funding - GenomeDx Biosciences
Jianbo Li
No relevant relationships to disclose
Andrew J. Stephenson
No relevant relationships to disclose
Kasra Yousefi
Employment or Leadership Position - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
Michael W. Kattan
Consultant or Advisory Role - GlaxoSmithKline
Cristina Magi-Galluzzi
Research Funding - GenomeDx Biosciences